Evidence map›Paper›PMID 41866515›Full record

ArticleJournal of medical case reports2026

Posterior reversible encephalopathy syndrome in a bilateral lung transplant recipient with subtherapeutic tacrolimus levels: a case report.

Aashish Maurya, Arthas Flabouris

Abstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Aashish MauryaGeneral Medicine Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia. ash.maurya@sa.gov.au.ORCID http://orcid.org/0009-0004-5551-8592
Arthas FlabourisIntensive Care Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPosterior reversible encephalopathy syndrome is a rare neurological disorder typically associated with hypertension, cytotoxic agents, or supratherapeutic immunosuppressant levels. We report what appears to be the first documented case of posterior reversible encephalopathy syndrome in a bilateral lung transplant recipient occurring with subtherapeutic tacrolimus levels. CASE PRESENTATION: A 59-year-old white male with prior bilateral lung transplantation and multiple risk factors, including sepsis, corticosteroid use, and acute kidney injury, presented with sudden bilateral cortical blindness and seizures, initially concerning for stroke. Tacrolimus levels were subtherapeutic. Rapid diagnosis of posterior reversible encephalopathy syndrome was made using computed tomography stroke perfusion imaging. Intensive blood pressure control and substitution of tacrolimus with cyclosporin led to complete neurological recovery.

conclusionThis case highlights the multifactorial nature of posterior reversible encephalopathy syndrome and the need for vigilance even when immunosuppressant levels are subtherapeutic. Early recognition and timely management can prevent irreversible neurological injury, with important implications for transplant care and immunosuppressive therapy monitoring.

Indexed as

Blindness, CorticalImmunosuppressive AgentsLung TransplantationPosterior Leukoencephalopathy SyndromeTacrolimusCyclosporineHumansMaleMiddle AgedSeizuresTomography, X-Ray ComputedTreatment OutcomeCyclosporineImmunosuppressive AgentsTacrolimusBlindnessLung transplantPosterior reversible encephalopathy syndromeSeizureTacrolimus

Identifiers

PMID41866515
PMCPMC13130437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.